BOLD
Boundless Bio, Inc.
2.46
+0.01 (+0.41%)
52w low 0.9610
3.16 high
68.0% of range
Financial Analysis
| (USD) | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 | Trend |
|---|---|---|---|---|---|---|
| Cash & Equivalents | -- | 10.95M | 23.71M | 26.59M | 17.87M | |
| Current Assets | -- | 68.04M | 124.20M | 154.39M | 109.61M | |
| Net PP&E | -- | 7.73M | 4.58M | 51.36M | 46.88M | |
| Total Assets | -- | 76.83M | 129.89M | 206.41M | 157.06M | |
| Current Liabilities | -- | 7.73M | 9.36M | 8.13M | 12.54M | |
| Total Debt | -- | 5.18M | 2.19M | 47.63M | 49.03M | |
| Total Liabilities | -- | 158.53M | 256.98M | 55.77M | 58.41M | |
| Retained Earnings | -- | -86.67M | -136.11M | -201.47M | -259.67M | |
| Shareholders Equity | -- | -81.70M | -127.08M | 150.64M | 98.65M | |
| Working Capital | -- | 60.31M | 114.84M | 146.25M | 97.07M | |
| Shares Outstanding | -- | 22.24M | 22.24M | 22.30M | 22.41M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--